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Abstract
Introduction: Acute esophageal necrosis (AEN) is an uncommon but fatal cause of upper gastrointestinal bleeding. The
complex pathophysiology of the disorder provides multiple points for intervention. Therefore, it is important to discuss
the many multifaceted aspects of the disease.
Methods: A scoping review was performed using PubMed, Google Scholar, and ClinicalTrials.gov. We reviewed literature
from 1990 to 2021. The keywords used were ‘acute esophageal necrosis’, ‘upper GI bleed’, ‘pathogenesis’, ‘EGD’, ‘prognosis’.
Results and conclusions: The review summarized ﬁndings of 46 studies. AEN usually targets older males who have
underlying cardiovascular disease. The middle part of the esophagus is commonly involved. The pathogenesis of AEN
depends on conditions that increase risk of mucosal damage such as ischemia, lack of mucosal protection and excessive
gastric reﬂux. Some medications are also responsible for the disease. Esophagogastroduodenoscopy is usually the gold
standard for diagnosis. Findings suggestive of AEN include darkened, sharply demarcated circumferential areas. Supportive measures, including bowel rest, ﬂuid supplementation and proton pump inhibitors are the cornerstone of
therapy. A high index of suspicion should be maintained in patients with chronic health problems presenting with signs
and symptoms of upper gastrointestinal bleeding because AEN can carry an unfavorable prognosis in these patients.
Keywords: Acute esophageal necrosis, upper GI bleed, pathogenesis, EGD, prognosis

1. Introduction

A

cute esophageal necrosis (AEN), also known
as necrotizing esophagitis or “black esophagus”, was ﬁrst described by Goldenberg et al., in
1990.1 While uncommon, the associated mortality
rate was as high as 32%.2 It typically presented in
elderly males with symptoms of upper gastrointestinal bleeding (UGB). Despite its alarmingly high
mortality rate, the condition has been poorly understood due to low incidences described by various
studies in the literature.3e8 The multifactorial etiology was attributed to a combination of esophageal
ischemia, impaired mucosal barrier protection, and
reﬂux esophagitis. Other risk factors included diabetes mellitus (particularly diabetic ketoacidosis),

hematologic and solid organ malignancies, malnutrition, gastric outlet obstruction, renal insufﬁciency,
hemodynamic compromise and shock; the underlying pathogenesis was related to poor perfusion
and nutritional states.9
Esophagogastroduodenoscopy is the gold standard modality for diagnosis.10 Biopsy, although not
required for deﬁnitive diagnosis, might be helpful in
excluding superimposed infections. Complications
included esophageal stenosis or stricture formation
in the distal esophagus, perforation and subsequent
infection.9 The main focus of management was to
correct the coexisting chronic medical conditions
and provide supportive treatment in the form of
ﬂuid therapy, NPO restriction maintenance and IV
Proton pump inhibitor therapy (PPI).10 Given the
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prevalence of its associated conditions, high mortality rate, and limited research data surrounding
AEN, it is imperative to attain a more comprehensive understanding of this condition in order to
achieve an early diagnosis and improve outcomes.

2. Methods
We screened PubMed, Web of Science, Google
Scholar and ClinicalTrials.gov databases for all articles about acute esophageal necrosis published
from 1990 to 2021. The keywords used in the review
were ‘acute esophageal necrosis’, ‘upper GI bleed’,
‘pathogenesis’, ‘EGD’, ‘prognosis’. After the initial
search, duplicates were removed and imported all
included search study into EndNote online software. Two independent reviewers screened
remaining studies for the inclusion based on inclusion criteria, and researchers were blinded to
each others' decisions. The inclusion criteria for the
review were as follows: 1) Literature from 1990 to
2021 about acute esophageal necrosis 2) Articles
discussing any aspect of acute esophageal necrosis
3) Fully retrievable articles. The exclusion criteria
were as follows: 1) Articles not in English language
2) Articles that could not be retrieved. The
screening was done via reading the abstract and if
needed by reading full-text articles. Studies published in the English language or with English
translation available, were included in the initial
review.
Data was extracted from study documents,
including information about epidemiology, etiology,
pathogenesis, clinical symptoms and signs, differential diagnoses, management, prognosis, and
complications. Data were cross-checked for accuracy and completeness. Publications that were not
peer-reviewed were excluded from this study.
For the purposes of the review, 10 studies discussing epidemiology, 4 studies regarding etiology
and pathogenesis respectively, 30 studies elaborating risk factors, 8 studies about clinical presentation, one study highlighting differential diagnoses,
two studies discussing complications, 9 studies
focusing on management and two studies about
prognosis were included.

3. Review
3.1. Epidemiology
Five retrospective studies3e7 and one prospective
study8 carried out between 1993 and 2011 have
established the incidence of AEN to be approximately 0.01e0.28%. AEN predominantly targeted
the 7th decade of life as evidenced by a mean age of
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62e67 years, typically affecting males 4 times more
than females.10 A pooled analysis of 114 diagnosed
cases of AEN by Schizas et al. reported cardiovascular disease as the most common pre-existing
condition (47.3%), followed by diabetes mellitus
(36.4%) alcohol abuse (28.2%), liver disease (17.3%)
and kidney disease (15.5%). The same study
exhibited lower esophageal involvement to be
almost universal (92.9%), with common disease
progression to the middle esophagus (64.3%). Upper
esophageal involvement was rare and seen in only
33.7% of cases.11
3.2. Etiology
The etiology of AEN was believed to be multifactorial; local hypoperfusion, loss of protective
mucosal barrier and reﬂex of gastric acid caused
tissue damage, initiating a cascade of events that
lead to tissue necrosis.10 The anatomy of the distal
esophagus contributed to perfusion injury in states
where circulatory volume is low. The distal esophagus receives its blood supply primarily from
branches of the left gastric artery or left inferior
phrenic artery and sometimes from small branches
of the celiac, splenic, short gastric, or left hepatic
arteries as additional or alternative anatomical variants.12,13 Compared to the well-vascularized proximal and middle parts of the organ, the distal
esophagus has more “watershed areas” making it
susceptible to ischemic injury. Overall, esophageal
infarction was a rare phenomenon due to the complex vascular anastomosis present in the esophageal
submucosa.13
3.3. Pathogenesis
The pathogenesis of AEN involved multiple underlying mechanisms working in tandem to cause
esophageal mucosal damage. This might include a
chronic condition that rendered the body susceptible to mucosal damage, followed by an acute event
that triggered AEN. Chronic predisposing conditions include conditions that increased the risk of
esophageal ischemia, or diminished the protective
capabilities of the esophageal mucosa, and or lead to
excessive gastric acid reﬂux into the distal
esophagus.14
The scarcely supplied distal esophagus was predisposed to ischemia in such low-ﬂow states, such
as hypotension and hypoperfusion. Patients with
vascular risk factors such as male sex, atherosclerosis, advanced age, diabetes mellitus, hypertension
or chronic kidney disease were at a higher risk of
developing esophageal ischemia.9
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Loss of the mucosal barrier was another mechanism contributing to AEN. Commonly seen in patients with poor nutritional status and general
debilitation, a weak protective barrier rendered the
mucosa more susceptible to gastric acid and other
irritants, impairing the mucosa's ability to withstand
chemical insults.8 This loss could be seen in patients
with chronic comorbidities including malignancy,
alcohol abuse, cirrhosis, chronic kidney disease,
congestive heart failure, chronic pulmonary disease,
and postoperative status.10 Gastric acid reﬂux also
played a role in the pathogenesis of this disease. An
impaired lower esophageal sphincter mechanism or
loss of peristalsis might result in acid reﬂux, which
can cause mucosal damage and subsequent necrotic
injury.14 In patients with a compromised mucosal
barrier due to the aforementioned conditions, acid
reﬂux could further exacerbate injury to the mucosal
lining.
These mechanisms coupled with a sudden precipitator such as hemodynamic compromise, metabolic derangements such as diabetic ketoacidosis,
infection, surgery, chemotherapy, certain medications and certain gastrointestinal procedures were
implicated in the development of AEN.
3.4. Risk factors and associated conditions
There are many risk factors predisposing patients
to AEN (Fig. 1). AEN had been reported in patients
presenting with hemodynamic compromise, particularly in patients with signiﬁcant vasculopathy secondary to diabetes mellitus, atherosclerosis,

Fig. 1. Risk factors predisposing to development of acute esophageal
necrosis.

cardiovascular and renal disease. In these patients,
hypotension might result in signiﬁcant hypoperfusion of the esophagus, eventually leading to
ischemic necrosis.9
Hemodynamic compromise might occur with any
type of shock. Cardiogenic shock leads to hypoperfusion that could cause ischemia of the esophagus. Septic shock following an infection causes
generalized vasodilation resulting in a state of
hypoperfusion. Both types of shock have poor
prognosis due to progression to multi-organ failure.15e17 Hemorrhagic shock can also cause hemodynamic compromise secondary to blood loss due to
causes such as variceal bleeding,18 aortic aneurysm
rupture,19,20 blunt thoracic trauma resulting in
transection of the aorta12 and post-surgical
bleeding.21 Hypovolemic shock may occur with
substantial ﬂuid loss secondary to diarrhea or
vomiting.
Diabetic ketoacidosis (DKA) is a well-documented
trigger of AEN.22e25 DKA leads to AEN through
several mechanisms. Patients with DKA typically
have a history of poor glycemic control which could
accelerate the development of atherosclerosis, thus
increasing the risk of developing ischemia in low
volume states. In fact, DKA might cause a low circulatory volume in itself via osmotic diuresis
resulting in profound ﬂuid loss.24 Furthermore,
DKA could induce gastric stasis resulting in
increased gastric reﬂux and subsequent mucosal
damage.9 A retrospective analysis performed by
Yasuda et al. demonstrated the association of DKA
with 4 of the 16 analyzed cases of AEN.26
Inﬂammatory states result in increased capillary
permeability, causing increased third spacing of
ﬂuid and subsequent low circulatory volume. This
could occur with infection and inﬂammation of
various organs and tissues including the gallbladder, pancreas, lung, endocardium, peritoneum,
subcutaneous tissue and bone. Malignancy could
also predispose to AEN due to immune dysregulation, resulting in diminished regenerative capacity
of the esophageal mucosal cells. There had been
documented cases of AEN induced by chemotherapeutic agents such as tacrolimus27 and ataﬁnib.28
Chronic alcohol abuse is another well documented predisposing factor, seen in as many as 25%
of patients with AEN.2 It might lead to AEN through
increased gastric acid secretions, reduced lower
esophageal sphincter pressure causing increased
reﬂux and poor nutritional status.29 Alcohol abuse
might predispose to cirrhosis, another documented
risk factor of AEN. Acute alcohol abuse in cases of
binge drinking could cause AEN due to esophageal
mucosal damage secondary to severe vomiting.30

The resulting hypovolemia and lactic acidosis could
trigger AEN.31
Surgery is a common precipitating factor for AEN,
being a cause for physiologic stress. The immune
system responds by increasing the amount of
circulating cytokines, thereby affecting the regenerative capacity of the esophageal mucosa.
Furthermore, blood loss associated with surgery can
induce a hypovolemic state and hinder perfusion.21
AEN had been documented following cardiac procedures, including radiofrequency ablation for atrial
ﬁbrillation32 and percutaneous coronary intervention.33 AEN might also be associated with certain
endoscopic procedures, including percutaneous
esophageal gastrostomy,34 insertion of biodegradable esophageal stents35 or photodynamic therapy
for esophageal carcinoma.36
Gastric outlet obstruction leads to prolonged
exposure of gastric contents in the distal esophagus
resulting in a breach of mucosal protective mechanisms. Such cases may occur secondary to gastric
ulcers and edema in the duodenal bulb.37 There was
a documented case of AEN secondary to gastrostomy tube migration into the duodenal bulb
resulting in obstruction at the gastric outlet.37
Certain medications are also implicated in the
development of AEN. Vasoconstrictors, such as
terlipressin38, could cause local ischemia whereas
antihypertensive drugs might lead to a transient
low-ﬂow state causing hypoperfusion.39 Drugs such
as NSAIDs26 and bisphosphonates40 might cause
direct mucosal damage.
3.5. Clinical presentation and diagnosis
The characteristic presentation of AEN is an
elderly man with multiple comorbidities demonstrating symptoms of UGB including hematemesis
or melena.10,11 Other symptoms might include chest
or epigastric pain, nausea, emesis, dysphagia, fever
or syncope. On admission, patients with AEN
commonly exhibited signs of hemodynamic
compromise such as tachycardia and hypotension.
Initial laboratory tests might show anemia secondary to blood loss, leukocytosis due to inﬂammation
caused by esophageal necrosis and an elevated
serum lactate due to tissue hypoperfusion.9
Esophagogastroduodenoscopy (EGD) is the diagnostic modality of choice for AEN. The characteristic
appearance of EGD is a circumferentially and
diffusely darkened esophagus, predominantly in the
distal part of the organ with continuation proximally
and sharply demarcated margins.10 The discoloration typically does not exceed beyond the gastroesophageal junction. This endoscopic ﬁnding is
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sufﬁcient for the diagnosis of AEN. Additional
ﬁndings may include active bleeding or blood clots
in the esophagus, or “coffee ground” material in the
stomach, as well as esophageal or gastric ulcers.9
A lack of viable epithelium, necrotic debris, and
necrotic changes in the mucosa with potential to
extend into the submucosa and even deeper into the
muscularis propria were important histological
ﬁndings. Other ﬁndings might include dense
leukocytic inﬁltrate, evident vascular thrombi,
deranged muscle ﬁbers, and alarming inﬂammatory
changes.9,41 Though not required to establish diagnosis, a biopsy of the specimen might help exclude
other differential diagnoses as well as infectious
etiologies of AEN and help rule out superimposed
infections.
Uncomplicated AEN follows a clinical course of
well-documented phases. The initial diffuse black
distal esophageal mucosa is followed by a healing
phase dominated by residual black areas and thick
white exudates composed of necrotic debris that
cover pink friable mucosa.37 Usually, esophageal
mucosa acquires its normal endoscopic appearance
in approximately 1e2 weeks. However, depending
on the patient's general condition, the time to
complete resolution might vary.9
3.6. Differential diagnosis
Due to the appearance of a darkened esophagus
on endoscopy, differential diagnoses of AEN
include malignant melanoma, acanthosis nigricans,
pseudomelanosis, and melanosis of the esophagus.
Esophageal erosion and necrosis is commonly seen
in cases of corrosive chemical ingestion, hence it
should be actively excluded in history. A biopsy of
the specimen can help exclude other causes of
similar appearance if there is uncertainty regarding
the underlying cause.9 (Table 1).
3.7. Complications
Perforation, the most feared complication of AEN
with an incidence of approximately 5e7%,2 occurs
due to transmural esophageal necrosis. Patients
with perforation decompensate rapidly and have a
poor prognosis. Since the esophagus lacks a serosa,
perforation might result in rapid development of
mediastinitis, mediastinal abscess formation or
sepsis, eventually culminating in multiorgan failure
and death.9 Other complications include esophageal
stenosis and stricture formation which result from
scar formation as AEN heals. Strictures were seen in
about 10% of patients on follow up EGD and might
cause dysphagia.2 The necrosed area of the
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Table 1. Differential diagnoses of acute esophageal necrosis.

Melanosis

Pseudomelanosis

Acanthosis Nigricans

Malignant Melanoma

Clinical Features

Imaging (EGD unless otherwise stated)

Biopsy ﬁndings










Acid reﬂux
Dysphagia
Heartburn
Indigestion
Epigastric pain
Nausea
Vomiting
Melena

Darkly pigmented desquamated patch in the esophagus










History of gastric cancer
Epigastric pain
Dysphagia
Dysphagia
Retrosternal or epigastric pain
Hematemesis
Melena
Weight loss

Thickened and ﬁnely granular esophageal mucosa with
several larger elevations
 EGD: lobulated and darkly
colored masses with intact
mucosa or occasional
ulceration
 CT: bulky esophageal mass
compressing the adjacent
mediastinal structures

 Hyperpigmentation at the basal
layer of the epithelium without
atypia
 immunohistochemistry
stain
positive for melanocytes
 Hyperpigmentation of the lamina propria by macrophages
laden with vesicles containing
mostly iron sulﬁde
 Papillomatous hyperplasia
 Pigmentation
 hyperkeratosis
 Melanin granules within the
tumor cells
 Melanocytes in the overlying
epithelial layer
 Areas of junctional activity
within squamous mucosa and
the adjacent epithelium

Sharply demarcated dark
pigmentation of the
esophagus

EGD-esophagogastroduodenoscopy, CT-computed tomography.

esophagus might also serve as a nidus for superimposed infections. A summary of the complications is presented in Fig. 2.
3.8. Management
The management of AEN focuses on counteracting the mechanisms that lead to its development
and minimizing risk factors (Fig. 3). Supportive care
and stabilization are the mainstay of therapy. Fluid
resuscitation assists in enhancing perfusion and
helps limit the damage caused by ischemia.14 Patients should be monitored and managed for anemia. Oral intake should be restricted for bowel rest
and parenteral nutrition can be instated, especially
in malnourished patients. Nasogastric tubes

Fig. 2. Complications of acute esophageal necrosis.

increase the risk of perforation and should be
avoided.9
The preferred medication for acid suppression is a
PPI, which could be transitioned to oral formulation
once clinical condition improves. Oral PPI therapy
should be continued for several months after resolution of symptoms to prevent stricture formation.14
Biopsy specimens can help identify underlying
infection. Appropriate antimicrobial therapy can be
selected using the results of esophageal cultures,
fungal stains or direct visualization of multinucleated giant cells or inclusion bodies. Empirical antibiotics might be initiated if perforation is suspected
or if there is evidence of rapid clinical decompensation, unexplained fevers or immunosuppression.
Otherwise, antibiotics are not recommended in the
management of AEN.9
Active bleeding could be controlled with submucosal adrenaline injections.39 Self-expanding
metallic covered stents placed endoscopically could
also help achieve hemostasis.42 Balloon tamponade
with a Sengstaken-Blakemore tube should be avoided because of the risk of perforation.43 In cases of
perforation resulting in mediastinitis or abscess
formation, surgical intervention is required. The
usual procedure is an emergent esophagectomy
followed by elective reconstruction using gastric or
enteric tube.35,43
A repeat endoscopy should be performed to
ensure disease resolution and identify potential
stricture formation 4 weeks after initial presentation.
The ﬁrst line treatment for strictures is endoscopic
balloon dilation with a large proportion of patients
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Fig. 3. An algorithm for managing acute esophageal necrosis.

requiring serial endoscopies with long term balloon
dilation therapy.44 If strictures persist despite serial
dilations, surgery is recommended which consists of
esophagectomy and esophageal bypass.45
3.9. Prognosis
Prognosis of AEN is dependent on the extent of
esophageal damage, the baseline medical conditions
and health status of the patient. Other prognostic
factors studied by Kim et al. include hemoglobin and
albumin levels as well as age, pulse rate, and sepsis.46
Overall, the mortality rate of AEN is high and was
established as 32% in a study conducted by Abdullah et al.2 However, this may likely be due to the

effect of simultaneous underlying critical illness.
The same study observed a favorable outcome in
more than 60% of patients who were treated
appropriately. Gurvits et al. argue the mortality due
to AEN itself is approximately 6%.10 Nonetheless,
AEN remains a disease with life-threatening potential which should be suspected in elderly males
with general debilitation and multiple medical
conditions, who also exhibit symptoms of UGB and
hemodynamic compromise.

4. Conclusion
AEN is a rare clinical syndrome occurring due to a
combination of esophageal ischemia, increased acid
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reﬂux, and reduced mucosal defenses. A high index
of suspicion should be maintained in elderly male
patients with chronic health problems presenting
with signs and symptoms of UGB. EGD is diagnostic
and demonstrates diffuse, circumferential darkening of the esophageal mucosa predominantly in
the distal esophagus, extending as far as the GEJ.
Treatment involves aggressive ﬂuid resuscitation,
NPO orders, IV proton pump inhibitors and red
blood cell transfusions. AEN can carry an unfavorable prognosis, in most part due to the severity of
underlying conditions present in most patients.
However, early management and treatment are vital
in reducing mortality, which can be achieved if clinicians have better understanding and awareness of
this condition.
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